Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic thromboembolic pulmonary hypertension

P F Fedullo1, W R Auger, R N Channick

  • 1Division of Pulmonary and Critical Care Medicine, University of California at San Diego, UCSD Medical Center, USA.

Clinics in Chest Medicine
|June 1, 1995
PubMed
Summary

Chronic thromboembolic pulmonary hypertension is treatable with surgery. Thromboendarterectomy can improve outcomes for patients with this major-vessel disease, but requires careful management throughout the perioperative period.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distribution of bluetongue in the United States of America, 1991-2002.

Veterinaria italiana·2010
Same author

Bluetongue surveillance methods in the United States of America.

Veterinaria italiana·2010
Same author

Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report.

Lupus·2008
Same author

Late onset thrombosis in a case of severe protein S deficiency due to compound heterozygosity for PROS1 mutations.

Journal of thrombosis and haemostasis : JTH·2008
Same author

Chronic thromboembolic pulmonary hypertension.

Seminars in respiratory and critical care medicine·2005
Same author

Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2.

The European respiratory journal·2004

Area of Science:

  • Cardiology
  • Pulmonary Medicine
  • Vascular Surgery

Background:

  • Chronic thromboembolic pulmonary hypertension (CTEPH) is a significant cause of pulmonary hypertension.
  • It arises from unresolved blood clots in the pulmonary arteries.
  • CTEPH is a potentially correctable condition, offering a chance for improved patient outcomes.

Purpose of the Study:

  • To review the comprehensive management of CTEPH.
  • To highlight the importance of understanding patient care aspects for optimal outcomes.
  • To discuss surgical intervention via thromboendarterectomy.

Main Methods:

  • Review of existing literature on chronic major-vessel thromboembolic disease.
  • Analysis of the natural history, evaluation, and surgical management of CTEPH.

Related Experiment Videos

  • Examination of the postoperative course following thromboendarterectomy.

    • Main Results:

    • CTEPH is a correctable cause of pulmonary hypertension.
    • Careful management is crucial for minimizing perioperative mortality.
    • Satisfactory long-term outcomes are achievable with appropriate intervention.

    Conclusions:

    • Thromboendarterectomy is a key surgical treatment for CTEPH.
    • A multidisciplinary approach is essential for managing patients with CTEPH.
    • Understanding the full spectrum of care improves patient prognosis.